Principles and applications of nanomaterial-based hyperthermia in cancer therapy
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kang J.K. | - |
dc.contributor.author | Kim J.C. | - |
dc.contributor.author | Shin Y. | - |
dc.contributor.author | Han S.M. | - |
dc.contributor.author | Won W.R. | - |
dc.contributor.author | Her J. | - |
dc.contributor.author | Park J.Y. | - |
dc.contributor.author | Oh K.T. | - |
dc.date.available | 2020-04-22T06:21:08Z | - |
dc.date.issued | 2020-01 | - |
dc.identifier.issn | 0253-6269 | - |
dc.identifier.issn | 1976-3786 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/38943 | - |
dc.description.abstract | Over the past few decades, hyperthermia therapy (HTT) has become one of the most promising strategies to treat cancer. HTT has been applied with nanotechnology to overcome drawbacks such as non-selectivity and invasiveness and to maximize therapeutic efficacy. The high temperature of HTT induces protein denaturation that leads to apoptosis or necrosis. It can also enhance the effects of other cancer therapies because heat-damaged tissues reduce radioresistance and help accumulate anticancer drugs. Gold nanoparticles and superparamagnetic iron oxide with different energy sources are commonly used as hyperthermia agents. New types of nanoparticles such as those whose surface is coated with several polymers and those modified with targeting moieties have been studied as novel HTT agents. In this review, we introduce principles and applications of nanotechnology-based HTT using gold nanoparticles and superparamagnetic iron oxide. © 2020, The Pharmaceutical Society of Korea. | - |
dc.format.extent | 12 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Pharmaceutical Society of Korea | - |
dc.title | Principles and applications of nanomaterial-based hyperthermia in cancer therapy | - |
dc.type | Article | - |
dc.identifier.doi | 10.1007/s12272-020-01206-5 | - |
dc.identifier.bibliographicCitation | Archives of Pharmacal Research, v.43, no.1, pp 46 - 57 | - |
dc.identifier.kciid | ART002556365 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 000515655800002 | - |
dc.identifier.scopusid | 2-s2.0-85078434346 | - |
dc.citation.endPage | 57 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 46 | - |
dc.citation.title | Archives of Pharmacal Research | - |
dc.citation.volume | 43 | - |
dc.type.docType | Review | - |
dc.publisher.location | 대한민국 | - |
dc.subject.keywordAuthor | Cancer therapy | - |
dc.subject.keywordAuthor | Gold nanoparticle | - |
dc.subject.keywordAuthor | Hyperthermia | - |
dc.subject.keywordAuthor | Nanotechnology | - |
dc.subject.keywordAuthor | SPIO | - |
dc.subject.keywordPlus | IRON-OXIDE NANOPARTICLES | - |
dc.subject.keywordPlus | GOLD NANOPARTICLES | - |
dc.subject.keywordPlus | MAGNETIC NANOPARTICLES | - |
dc.subject.keywordPlus | PHOTOTHERMAL THERAPY | - |
dc.subject.keywordPlus | DRUG-DELIVERY | - |
dc.subject.keywordPlus | IN-VITRO | - |
dc.subject.keywordPlus | TARGETED HYPERTHERMIA | - |
dc.subject.keywordPlus | HEATING EFFICIENCY | - |
dc.subject.keywordPlus | CONTRAST AGENT | - |
dc.subject.keywordPlus | SIZE | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.